(Q34708953)

4 August 2017

1 reference

title

Oral hypoglycaemic agents. An update (English)

1 reference

4 August 2017

Asmal AC

1

1 reference

PubMed ID

6378583

4 August 2017

Marble A

series ordinal

2

1 reference

4 August 2017

1 July 1984

1 reference

4 August 2017

1 reference

4 August 2017

28

1 reference

4 August 2017

62-78

1 reference

4 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198428010-00004

4 August 2017

0 references

cites work

Pharmacokinetics of blood glucose lowering biguanide derivatives

1 reference

12 December 2020

Efficacy and safety of oral hypoglycemic agents

1 reference

12 December 2020

The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects

1 reference

12 December 2020

Drug-induced hypoglycemia. A review based on 473 cases

1 reference

12 December 2020

Assessment of the Need for Continued Oral Therapy in Diabetics

1 reference

12 December 2020

Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

1 reference

12 December 2020

The effect of long-term glibenclamide treatment on glucose tolerance, insulin secretion and serum lipids in subjects with impaired glucose tolerance.

1 reference

12 December 2020

Effect of sulfonylureas on calcium uptake and insulin secretion by islets of Langerhans

1 reference

12 December 2020

Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics.

1 reference

12 December 2020

Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide

1 reference

12 December 2020

Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.

1 reference

12 December 2020

Effect of prolonged glyclazide treatment on blood glucose and plasma insulin responses in obese patients with maturity-onset diabetes

1 reference

12 December 2020

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

1 reference

12 December 2020

Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide

1 reference

12 December 2020

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

1 reference

12 December 2020

Diabetes mellitus treated with chlorpropamide and tolbutamide. A four-year clinical study

1 reference

12 December 2020

Extrapancreatic effects of sulfonylureas. Potentiation of insulin action through post-binding mechanisms

1 reference

12 December 2020

Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients

1 reference

12 December 2020

Glipizide versus tolbutamide in maturity-onset diabetes, an open comparative study

1 reference

12 December 2020

PHENFORMIN IN WEIGHT REDUCTION OF OBESE DIABETICS

1 reference

12 December 2020

Effects of Glipizide and Food Intake on the Blood Levels of Glucose and Insulin in Diabetic Patients

1 reference

12 December 2020

The long-term effects of chlorpropamide on insulin, C-peptide, and proinsulin secretion.

1 reference

12 December 2020

Nine years' experience with tolbutamide in the treatment of diabetes

1 reference

12 December 2020

The long-term use of sulphonylureas in diabetes mellitus

1 reference

12 December 2020

TOLAZAMIDE (TOLANASE) -- A NEW SULPHONYLUREA

1 reference

12 December 2020

Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

1 reference

12 December 2020

Phenformin-induced lactic acidosis in diabetic patients

1 reference

12 December 2020

Treatment of the obese diabetic. A comparative study of placebo, sulfonylurea and phenformin

1 reference

12 December 2020

Reduction of Insulin Resistance in Obese and/or Diabetic Animals by 5-[4-(1-Methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, Ciglitazone), a New Antidiabetic Agent

1 reference

12 December 2020

Malabsorption of Vitamin B12 in Diabetic Patients Treated with Phenformin: A Comparison with Metformin

1 reference

12 December 2020

Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.

1 reference

12 December 2020

Effect of biguanides on intestinal absorption of glucose

1 reference

12 December 2020

Diurnal Variations of Serum Insulin, Total Glucagon, Cortisol, Glucose and Free Fatty Acids in Normal and Diabetic Subjects before and after Treatment with Chlorpropamide

1 reference

12 December 2020

Long-Term Experience with Sulfonylureas and Placebo

1 reference

12 December 2020

Inhibition of bile salt absorption by blood-sugar lowering biguanides

1 reference

12 December 2020

LONG-TERM USE OF CHLORPROPAMIDE IN DIABETES.

1 reference

12 December 2020

1 reference

12 December 2020

Clinical experience with glibenclamide in long-term treatment of diabetes mellitus

1 reference

12 December 2020

Trial of placebo in long-term chlorpropamide-treated diabetics

1 reference

12 December 2020

Phenformin in Insulin-Dependent Diabetics

1 reference

12 December 2020

Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas

1 reference

12 December 2020

Ciglitazone, a New Hypoglycemic Agent: II. Effect on Glucose and Lipid Metabolisms and Insulin Binding in the Adipose Tissue of C57BL/6J-ob/ob and − + / ? Mice

1 reference

12 December 2020

Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs

1 reference

12 December 2020

Phenformin increases insulin binding to human cultured breast cancer cells

1 reference

12 December 2020

Insulin secretion studied in the perfused rat pancreas. I. Effect of tolbutamide, leucine and arginine; their interaction with diazoxide, and relation to glucose

1 reference

12 December 2020

Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden)

1 reference

12 December 2020

Sulphonylureas increase the number of insulin receptors

1 reference

12 December 2020

The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes

1 reference

12 December 2020

Transglutaminase is essential in receptor-mediated endocytosis of α2-macroglobulin and polypeptide hormones

1 reference

12 December 2020

Glucose and Insulin Secretory Response Patterns Following Diet and Tolazamide Therapy in Diabetes

1 reference

12 December 2020

The Adenylate cyclase-cyclic AMP system in islets of langerhans and its role in the control of insulin release

1 reference

12 December 2020

Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels

1 reference

12 December 2020

Ciglitazone, a New Hypoglycemic Agent: I. Studies in ob/ob and db/db Mice, Diabetic Chinese Hamsters, and Normal and Streptozotocin-Diabetic Rats

1 reference

12 December 2020

Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide

1 reference

12 December 2020

THE FATE OF BIGUANIDES IN MAN

1 reference

12 December 2020

Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjects

1 reference

12 December 2020

Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells

1 reference

12 December 2020

Pharmacogenetics of tolbutamide metabolism in humans

1 reference

12 December 2020

Anti-platelet effects of long-term treatment with gliclazide in diabetic patients

1 reference

12 December 2020

Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.

1 reference

12 December 2020

Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets

1 reference

12 December 2020

The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects.

1 reference

12 December 2020

A five-year study of tolbutamide in the treatment of diabetes mellitus

1 reference

12 December 2020

The effect of phenformin hydrochloride on serum cholesterol and triglyceride levels of the stable adult diabetic

1 reference

12 December 2020

Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics.

1 reference

12 December 2020

Clinical and experimental findings after five years' treatment of diabetes with sulfonylureas

1 reference

12 December 2020

Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.

1 reference

12 December 2020

The hypoglycemic action of phenformin. Effect of phenformin on glucose metabolism in peripheral tissues

1 reference

12 December 2020

Effect of Phenformin on Water and Glucose Transport Across Isolated Human Ileum

1 reference

12 December 2020

Some new aspects on the interaction of hypoglycemia-producing biguanides with biological membranes

1 reference

12 December 2020

High density lipoproteins in diabetes

1 reference

12 December 2020

Sulfonylurea treatment of insulin-independent diabetes mellitus

1 reference

12 December 2020

Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations

1 reference

12 December 2020

Pancreatic action of the sulfonylureas

1 reference

12 December 2020

Extrapancreatic effect of glibenclamide: Stimulation of duodenal insulin-releasing activity (DIRA) in man

1 reference

12 December 2020

Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide

1 reference

12 December 2020

Clinical experience with sulfonylurea compounds in diabetes

1 reference

12 December 2020

Clinical pharmacology of oral antidiabetic agents (first of two parts).

1 reference

12 December 2020

Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity.

1 reference

12 December 2020

The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy

1 reference

12 December 2020

Insulin treatment reverses the insulin resistance of type II diabetes mellitus.

1 reference

12 December 2020

Biguanides. A review of history, pharmacodynamics and therapy

1 reference

12 December 2020

Diarrhea and Metformin in a Diabetic Clinic

1 reference

12 December 2020

Preventive effect of gliclazide on experimental atherosclerosis in rabbits

1 reference

12 December 2020

Lactic acidosis in biguanide-treated diabetics: a review of 330 cases

1 reference

12 December 2020

Inhibition of gluconeogenesis from lactate by phenylethylbiguanide in the perfused guinea pig liver

1 reference

12 December 2020

Inhibition of intestinal amino acid transport by blood sugar lowering biguanides

1 reference

12 December 2020

Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors

1 reference

12 December 2020

Evaluation of duration of action and clinical effectiveness of acetohexamide

1 reference

12 December 2020

LONG-TERM OBSERVATIONS ON ORAL HYPOGLYCEMIC AGENTS IN DIABETES; THE EFFECT OF CARBUTAMIDE AND TOLBUTAMIDE

1 reference

12 December 2020

Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas

1 reference

12 December 2020

Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics

1 reference

12 December 2020

Inhibition of cyclic 3',5'-AMP phosphodiesterase in islet cells and other tissues by tolbutamide.

1 reference

12 December 2020

Incidence and causes of secondary failure in treatment with tolbutamide. Experience with 2,500 patients treated up to five years

1 reference

12 December 2020

Plasma concentrations, bioavailability and dissolution of chlorpropamide

1 reference

12 December 2020

Clinical experience with chlorpropamide and comparative evaluation with tolbutamide

1 reference

12 December 2020

Metabolism of chlorpropamide

1 reference

12 December 2020

10.2165/00003495-198428010-00004

Identifiers

DOI

1 reference

PubMed ID

6378583

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

6378583